MA
FRTX

MUFG Americas’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

MUFG Americas’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3
Closed -$4K – 1225
2015
Q3 		$4K Hold
3
– – ﹤0.01% 1014
2015
Q2 		$6K Hold
3
– – ﹤0.01% 951
2015
Q1 		$8K Buy
3
+1
+50% +$3.2K ﹤0.01% 958
2014
Q4 		$7K Buy
+2
New +$7.08K ﹤0.01% 1045

Other funds holding FRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SAIG
Semper Augustus Investments Group Highlands Ranch, Colorado $837M AUM 42.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MUFG Americas's FRTX Position: Q4 2015 in Review

MUFG Americas sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2015, closing a stake of 3 shares — an estimated $4K sold.

MUFG Americas first reported a position in FRTX in Q4 2014 and held it in 4 quarters. The position peaked at $8K in Q1 2015. 41 funds tracked by Wall St. Rank hold FRTX as of Q4 2015.

  • MUFG Americas reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • MUFG Americas sold 3 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $4K.
  • MUFG Americas first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q4 2014 and held it in 4 quarters.
  • MUFG Americas's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $8K in Q1 2015.
  • 41 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2015.

Based on MUFG Americas's 13F filing for Q4 2015, filed 10 Feb 2016.